期刊文献+

CDKN2A基因座在膀胱癌中的表达及临床意义 被引量:4

Expression of CDKN2A gene locus in bladder carcinoma and clinical significance
下载PDF
导出
摘要 目的:探讨CDKN2A基因座两种编码产物p16INK4A和p14ARF在膀胱癌组织中的表达及其临床意义。方法:采用免疫组织化学技术SP法观察13例正常膀胱组织和52例膀胱尿路上皮癌组织中p16 INK4 A和p14 ARF的表达情况。结果:p16INK4A在正常组织、膀胱癌中阳性表达率分别为84. 62%(11/13)、40. 38%(21/52),两组间差异显著(P <0. 01)。p14ARF在正常膀胱组织、膀胱癌中阳性表达率分别为92. 31%(12/13)、23. 08%(12/52),两组间差异显著(P <0. 01)。p16INK4A和p14ARF的阳性表达率与肿瘤病理分级、临床分期呈负相关(P <0. 05);两者在膀胱癌中的表达没有相关性(P> 0. 05),但他们均与患者的预后正相关(P <0. 05)。结论:p16INK4A和p14ARF在膀胱癌中的表达异常与膀胱癌的发生发展密切相关,但它们所起的生物学作用不尽相同,联合检测两者的表达可能为膀胱癌的早期诊断及预后判断提供帮助。 Objective:To study the expression and implication of p16INK4A and p14ARF in human bladder carcinoma.Methods:Immunohistochemistry method was used to detect p16INK4A and p14ARF expressions in 13 normal bladder tissues and 52 primary bladder carcinoma.Results:The positive expression rate of p16INK4A in normal bladder tissues and primary bladder carcinoma tissues was 84.62%and 40.38%,respectively.There was significant difference between them(P<0.01).The positive expression rate of p14ARF in normal bladder tissues and primary bladder carcinoma tissues was 92.31%and 23.08%,respectively(P<0.01).The positive expression rate of p16INK4A and p14ARF had negative correlation with clincopathological stages and pathlolgyical grades(P<0.05).The expression of p16INK4A and p14ARF in bladder carcinoma had not a positive correlation(P>0.05).But there were relation between p16INK4A,p14ARF and prognosis(P<0.05).Conclusion:Expression of p16INK4A and p14ARF in bladder carcinoma play an important role in suppression of invasive growth and metastasis of tumor,which might contribute to various biological behaviors.United detection of p16INK4A and p14ARF might be acted as an marker of bladder carcinoma diagnosis and prognosis.
作者 杨军 张景宇 王芳芳 张志超 付桥 郭洁 Yang Jun;Zhang Jingyu;Wang Fangfang;Zhang Zhichao;Fu Qiao;Guo Jie(Department of Urology,the Third Hospital of Wuhan,Hubei Wuhan 430060,China;Department of Digestion,the First Hospital of Wuhan,Hubei Wuhan 430022,China.)
出处 《现代肿瘤医学》 CAS 2019年第1期83-86,共4页 Journal of Modern Oncology
基金 武汉市科技晨光计划(编号:20055003059-41)
关键词 膀胱癌 P16INK4A P14ARF 免疫组织化学 bladder carcinoma p16INK4A p14ARF immunohistochemistry
  • 相关文献

参考文献5

二级参考文献28

  • 1Xiu-Sheng He Qi Su Zhu-Chu Chen Xiu-Tao He Zhi-Feng Long Hui Ling Liang-Run Zhang Oncology Institute,Nanhua University,Hengyang 421001,Hunan Province,ChinaOncology Institute,Center South University,Changsha 410078,Hunan Province,China Department of Gastroenterology,First People’s Hospital of Changde City,Changde 415003,Hunan Province,China.Expression,deleton and mnutation of ρ16 gene in human gastric cancer[J].World Journal of Gastroenterology,2001,7(4):515-521. 被引量:40
  • 2王固新,党建功,南勋义.MTS1基因在肾癌中的表达及其与预后的关系[J].中国现代医学杂志,2004,14(16):53-54. 被引量:1
  • 3贺荣芳,胡忠良,沈明,文继舫.胃癌组织中PTEN,VEGF,MMP-9的表达及相关性研究[J].中国普通外科杂志,2005,14(3):173-177. 被引量:39
  • 4平季根,郭震华,陈赐龄,王晖.抑癌基因P16在膀胱移行细胞癌中表达的意义[J].临床泌尿外科杂志,1997,12(1):36-38. 被引量:7
  • 5程伟,邵国兴,赵世平,康安静.nm23基因产物/NDPK在膀胱癌中的表达及其临床意义[J].中华泌尿外科杂志,1997,18(7):440-440. 被引量:5
  • 6GERADTS J, KR ATZKERA, NIEHANSGA, et al. Immunities medical detection of the cyclin dependent kinas inhibitor 2 multiple tumor suppressor gene 1 (CDKN2/MST1) product p16 in archival human solid tumors: correlation with retinoblastoma protein expression[J]. Cancer Res, 1995, 55: 6006-6011.
  • 7KRATZKE RA, GREATENS TM, RUBINS JB, et al. Rb and p16INK4 expression respected non-small cell lung tumors [J]. Cancer RES, 1996, 56: 3415-3420.
  • 8HIPAMA T, KOEFFLER HP. Role of the cyclin-dependent Kinase inhibitors in the development of cancer[J]. Blood, 1995, 86: 841-854.
  • 9ALLAY JA, STEINER MS, ZHANG Y, et al. Adenovirus p16 gene therapy for prostate cancer [J]. World J UROL, 2000, 18: 111-120.
  • 10OKAMOTO A, DEMETUICK DJ, Spillart EA, et al. Mutations and altered expression of p16 (INK4) in human cancer[J]. Prenatal Aced Sick USA, 1994, 19: 11045-11049.

共引文献12

同被引文献37

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部